DRTS — Alpha Tau Medical Balance Sheet
0.000.00%
- $263.93m
- $190.26m
- 24
- 25
- 65
- 30
Annual balance sheet for Alpha Tau Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 46 | 31.3 | 105 | 81.8 | 59.6 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.005 | 0.022 | 0.032 | 0.019 | 0.017 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 47.5 | 32.6 | 106 | 85.8 | 64.2 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 5.39 | 7.55 | 13.3 | 21.2 | 21.5 |
| Other Long Term Assets | |||||
| Total Assets | 53 | 42.2 | 120 | 107 | 86.2 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.09 | 4.41 | 4.34 | 7.1 | 8.68 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 7.45 | 23 | 14.5 | 22.9 | 23.5 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 45.5 | 19.2 | 106 | 84.5 | 62.7 |
| Total Liabilities & Shareholders' Equity | 53 | 42.2 | 120 | 107 | 86.2 |
| Total Common Shares Outstanding |